3,4-dihydro-2H-pyran → tetrahydro-pyran-2-yl-1H-pyrazole-3-carboxylic acid [4-(tetrahydro-pyran-2-yloxy)-cyclohexyl]-amide

HRID 132038

Reaktionsgleichung

Reaktionsgleichung von HRID 132038
[OH:1][CH:2]1[CH2:7][CH2:6][CH:5]([NH:8][C:9]([C:11]2[C:15]([N+]([O-])=O)=[CH:14][NH:13][N:12]=2)=[O:10])[CH2:4][CH2:3]1.[O:19]1[CH:24]=[CH:23][CH2:22][CH2:21][CH2:20]1.O.C1(C)C=CC(S(O)(=O)=O)=CC=1.[O:37]1[CH:42]=[CH:41][CH:40]=[CH:39][CH2:38]1>C(Cl)Cl.C(Cl)(Cl)Cl.C1COCC1>[O:19]1[CH2:20][CH2:21][CH2:22][CH2:23][CH:24]1[O:1][CH:2]1[CH2:3][CH2:4][CH:5]([NH:8][C:9]([C:11]2[CH:15]=[CH:14][N:13]([CH:38]3[CH2:39][CH2:40][CH2:41][CH2:42][O:37]3)[N:12]=2)=[O:10])[CH2:6][CH2:7]1

Komponenten

8

Versuchsvorschrift

A solution of 4-nitro-1H-pyrazole-3-carboxylic acid 4-hydroxy-cyclohexylamide (1.95 g; 7.67 mmol) in a mix of THF (50 ml) and chloroform (100 ml), was treated with 3,4-dihydro-2H-pyran (1.54 ml, 15.34 mmol) and p-toluenesulphonic acid monohydrate (100 mg). The reaction mixture was stirred at room temperature overnight, and then excess pyran (0.9 ml) was added in total to bring reaction to completion. The reaction mixture was diluted with CH2Cl2 and washed successively with saturated aqueous sodium bicarbonate, water and brine. The resulting solution was reduced in vacuo and subject to Biotage column chromatography, eluting with hexane (2 column lengths) followed by 30% ethyl acetate: hexane (10 column lengths), 70% ethyl acetate: hexane (10 column lengths) to give 1.25 g of 4-nitro-1-(tetrahydro-pyran-2-yl-1H-pyrazole-3-carboxylic acid [4-(tetrahydro-pyran-2-yloxy)-cyclohexyl]-amide. (LC/MS: Rt 2.97, [M+H]+423).

Aufarbeitung

  1. customreaction to completion
  2. washwashed successively with saturated aqueous sodium bicarbonate, water and brine
  3. washeluting with hexane (2 column lengths)

Quellen und Nachweise

ORD-Eintrag
ord-51b911fe162942618705ad3bdd90c805
Quelldatensatz
uspto-grants-2008_06
Patentnummer
US07385059B2

Verknüpfte Notizen

Wird geladen…